Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic Regions
Background: nasopharyngeal carcinoma (NPC) is a complex disease entity that mainly predominates in endemic regions.Real-world data with immunotherapy from nonendemic regions are limited.Methods: we collected data from patients with recurrent/metastatic (R/M) NPC treated at a center in Greece and 8 centers in Italy.Between 2016 and 2021, 46 patients